Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, 89bio Inc (NASDAQ: ETNB) closed at $8.01 down -12.46% from its previous closing price of $9.15. In other words, the price has decreased by -$12.46 from its previous closing price. On the day, 2.29 million shares were traded. ETNB stock price reached its highest trading level at $9.21 during the session, while it also had its lowest trading level at $7.865.
Ratios:
For a deeper understanding of 89bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.19 and its Current Ratio is at 13.19. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on March 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $11.
On March 13, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 30 ’25 when RA CAPITAL MANAGEMENT, L.P. bought 5,714,285 shares for $8.75 per share. The transaction valued at 49,999,994 led to the insider holds 19,554,319 shares of the business.
McWherter Charles bought 10,000 shares of ETNB for $67,100 on Jan 22 ’25. The Director now owns 25,000 shares after completing the transaction at $6.71 per share. On Jan 21 ’25, another insider, McWherter Charles, who serves as the Director of the company, bought 5,000 shares for $6.55 each. As a result, the insider paid 32,750 and bolstered with 15,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 1335755648 and an Enterprise Value of 766927296.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.21, which has changed by -0.2917772 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $11.84, while it has fallen to a 52-week low of $5.99. The 50-Day Moving Average of the stock is -10.46%, while the 200-Day Moving Average is calculated to be -5.27%.
Shares Statistics:
For the past three months, ETNB has traded an average of 2.35M shares per day and 2341170 over the past ten days. A total of 145.98M shares are outstanding, with a floating share count of 140.33M. Insiders hold about 3.88% of the company’s shares, while institutions hold 89.65% stake in the company. Shares short for ETNB as of 1740700800 were 9651177 with a Short Ratio of 4.11, compared to 1738281600 on 8338983. Therefore, it implies a Short% of Shares Outstanding of 9651177 and a Short% of Float of 7.88.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of 89bio Inc (ETNB) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.4 and low estimates of -$0.71.
Analysts are recommending an EPS of between -$1.83 and -$2.92 for the fiscal current year, implying an average EPS of -$2.18. EPS for the following year is -$2.05, with 7.0 analysts recommending between -$1.36 and -$2.57.
